Advertisement

Topics

Endosense Company Profile

17:09 EDT 21st September 2017 | BioPortfolio

Founded in Geneva in 2003, Endosense is a medical technology company focused on improving efficacy, safety and reproducibility of catheter ablation for the treatment of cardiac arrhythmias. The company has pioneered the use of contact force measurement in catheter ablation, with the development of its proprietary Touch+® sensor technology. Endosense’s flagship product is the TactiCath, the first force-sensing ablation catheter to give physicians a real-time, objective measure of contact force during the catheter ablation procedure.


News Articles [1 Associated News Articles listed on BioPortfolio]

Abbott releases contact force ablation catheter in select European markets

The TactiCath contact force ablation catheter, a combination of the Endosense device and the EnSite Precision cardiac mapping -More- 

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

Endosense

Founded in Geneva in 2003, Endosense is a medical technology company focused on improving efficacy, safety and reproducibility of catheter ablation for the treatment of cardiac ar...

Ysios Capital

Ysios Capital is an independent venture capital firm providing private equity financing to early through late-stage human healthcare and biotechnology companies with special focus...

More Information about "Endosense" on BioPortfolio

We have published hundreds of Endosense news stories on BioPortfolio along with dozens of Endosense Clinical Trials and PubMed Articles about Endosense for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Endosense Companies in our database. You can also find out about relevant Endosense Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record